Received: 18 March 2021
Accepted: 1 June 2021
First Online: 23 June 2021
: Record linkage studies using NHS data in Scotland are governed by the Public Benefit and Privacy Panel for Health and Social Care. This study was approved under COVID-19 Rapid Data Protection Impact Assessment 20210023 that allows Public Health Scotland staff to link datasets without requiring individual consent and to make de-identified datasets available for analysis within Public Health Scotland.
: Not applicable
: HC receives research support and honoraria and is a member of advisory panels or speaker bureaus for Sanofi Aventis, Regeneron, Novartis, Novo-Nordisk and Eli Lilly. HC receives or has recently received non-binding research support from AstraZeneca and Novo-Nordisk. SH received honoraria from Gilead.